March 2019 Briefing - RheumatologyLast Updated: April 01, 2019.
Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for March 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Patients With Worse RA Symptoms More Likely to Cut Alcohol Intake
FRIDAY, March 29, 2019 (HealthDay News) -- Higher disease activity, disability, comorbidity, and poor quality of life contribute to reductions in alcohol use among patients with rheumatoid arthritis (RA), according to a study published online March 20 in Arthritis Care & Research.
Cimzia Injection Approved for New Inflammatory Arthritis Indication
THURSDAY, March 28, 2019 (HealthDay News) -- Cimzia (certolizumab pegol) injection has been approved to treat adults with nonradiographic axial spondyloarthritis (nr-axSpA) with objective signs of inflammation, the U.S. Food and Drug Administration announced.
Doctors With Malpractice Claims More Likely to Leave Medicine
THURSDAY, March 28, 2019 (HealthDay News) -- Physicians with one or more paid malpractice claims are more likely to leave practice or shift into smaller practice settings, according to a study published in the March 28 issue of the New England Journal of Medicine.
Higher Disease Burden for OA Than RA After Six Months
WEDNESDAY, March 27, 2019 (HealthDay News) -- After six months, osteoarthritis (OA) is associated with higher mean disease burden than rheumatoid arthritis (RA), according to a study published online March 20 in Arthritis & Rheumatology.
Douglas County, Colorado, Ranked as Healthiest Community
TUESDAY, March 26, 2019 (HealthDay News) -- The 2019 healthiest community in America is Douglas County, Colorado, according to a report published online March 26 by U.S. News & World Report, in conjunction with the Aetna Foundation.
2019 Residency Match Day Was Largest in History
MONDAY, March 25, 2019 (HealthDay News) -- The 2019 Main Residency Match was the largest in history, with a record high of 38,376 applicants for 35,185 positions, according to 2019 Match Day results released by the National Resident Matching Program.
Overall, Physicians Are Happy and Enjoy Their Lives
WEDNESDAY, March 20, 2019 (HealthDay News) -- Overall, physicians are happy and enjoy their lives, according to the 2019 American Academy of Family Physicians (AAFP)/CompHealth Physician Happiness Survey published online March 19.
Average of 8.8 Inactive Ingredients Found in Oral Medications
MONDAY, March 18, 2019 (HealthDay News) -- Oral forms of medications contain an average of 8.8 inactive ingredients, many of which could cause adverse reactions, according to a perspective piece published in the March 13 issue of Science Translational Medicine.
Physician Burnout Rate Increased From 2014 to 2017
FRIDAY, March 15, 2019 (HealthDay News) -- From 2014 to 2017, there was an increase in physician burnout, with early-career physicians being the most susceptible, according to a study published online March 15 in JAMA Network Open.
Knee Pain Not Tied to Activity Levels in Knee Osteoarthritis
THURSDAY, March 14, 2019 (HealthDay News) -- Knee pain is not associated with daily walking levels in individuals with mild-to-moderate, symptomatic knee osteoarthritis (KOA), according to a study published online March 6 in Arthritis Care & Research.
Head of National Cancer Institute Named Acting FDA Commissioner
WEDNESDAY, March 13, 2019 (HealthDay News) -- The U.S. Food and Drug Administration will temporarily be overseen by the head of the National Cancer Institute when FDA Commissioner Scott Gottlieb, M.D., leaves the post next month.
CDC: Most Americans Report Excellent, Good Health
WEDNESDAY, March 13, 2019 (HealthDay News) -- Most Americans report having excellent or good health and have a usual place to go for medical care, according to a report published March 13 for the National Health Interview Survey Early Release Program.
Tramadol May Up Mortality Risk in Osteoarthritis Patients
TUESDAY, March 12, 2019 (HealthDay News) -- The initial prescription of tramadol compared with commonly prescribed nonsteroidal anti-inflammatory drugs may be associated with increased all-cause mortality among patients with osteoarthritis, according to a study published in the March 12 issue of the Journal of the American Medical Association.
Patterns of Joint Behavior Useful for Juvenile Arthritis Classification
MONDAY, March 11, 2019 (HealthDay News) -- An algorithm that can classify patients with juvenile idiopathic arthritis (JIA) into seven distinct groups based on patterns of swollen or painful joints in the body can help predict disease course, according to a study published online Feb. 26 in PLOS Medicine.
FDA Commissioner Dr. Scott Gottlieb Resigns
TUESDAY, March 5, 2019 (HealthDay News) -- In what probably came as a surprise to many, U.S. Food and Drug Administration Commissioner Scott Gottlieb, M.D., announced his resignation on Tuesday. Gottlieb is leaving the FDA because he wants to spend more time with his wife and three young daughters -- twins aged 9 and a 5-year-old -- one official said. He currently commutes each week from the family home in Connecticut to his Washington, D.C., office.
Recommendations Developed for Ulcerative Colitis Management
TUESDAY, March 5, 2019 (HealthDay News) -- Recommendations have been developed for management of adults with ulcerative colitis (UC); the American College of Gastroenterology clinical guideline was published online Feb. 21 in the American Journal of Gastroenterology.
Program in Peds Rheumatology Clinic Ups Education on Teratogenic Rx
TUESDAY, March 5, 2019 (HealthDay News) -- A series of interventions introduced through a quality improvement project can increase the frequency of both teratogen education and urine pregnancy screening in patients taking teratogenic medications for rheumatic disease, according to a study published online March 5 in Pediatrics.
FDA Warns Americans Not to Buy Drugs From Canadian Company
FRIDAY, March 1, 2019 (HealthDay News) -- A large Canadian drug distributor sells unapproved and mislabeled medicines to Americans, the U.S. Food and Drug Administration warned Thursday. The distributor disputes the claim, however.
|Previous: March 2019 Briefing - Pulmonology||Next: March 2019 Briefing - Surgery|
Reader comments on this article are listed below. Review our comments policy.